Table 2 Factors potentially associated with new HBV or HCV infection in HD centres
Factors potentially associated with new HBV±HCV infection | Sero-converted | Stayed sero-negative | P- value | ||
|---|---|---|---|---|---|
| Â | N=89 | N=1071 | Â | ||
| Â | Number* | Value | Number* | Value | Â |
Age in years (mean± SD) | 89 | 50.9±15.8 | 1071 | 50±16.6 | 0.635 |
Males (number and percent) | 89 | 54(60.7%) | 1071 | 613(57.2%) | 0.528 |
Whites (number and percent) | 89 | 75 (84.3%) | 1056 | 927 (87.8%) | 0.335 |
Dialysis vintage in years (mean± SD) | 89 | 4.1±4.4 | 1071 | 2.2±2.6 | 0.001 |
Previous blood transfusion (number and percent) | 45 | 34 (75.6%) | 716 | 481(67.2%) | 0.244 |
Number of blood transfusions (mean± SD) | 45 | 3.6±6.9 | 716 | 1.8±2.6 | 0.083 |
Previous renal transplant (number and percent) | 89 | 6 (6.7%) | 1064 | 28 (2.6%) | 0.028 |
Previous dialysis abroad (number and percent) | 48 | 27 (56.3%) | 714 | 395 (55.3%) | 0.900 |
Previous dialysis in another Libyan centre (number and percent) | 48 | 31 (64.6%) | 707 | 371(52.5%) | 0.023 |
Haemoglobin level in g/dl (mean± SD) | 89 | 9.9±2.1 | 1071 | 9.6±1.8 | 0.220 |
Alanine Aminotransferase in IU/L (mean± SD) | 27 | 21.9±22.7 | 274 | 18.6±17.8 | 0.272 |
Aspartate Aminotransferase in IU/L (mean± SD) | 24 | 23±23.8 | 252 | 20.8±21.2 | 0.925 |
Diabetes (number and percent) | 89 | 35 (39.3%) | 1071 | 385 (35.9%) | 0.524 |
Erythropoietin treatment (number and percent) | 51 | 7 (13.7%) | 729 | 100 (13.7%) | 0.999 |